AT&S considers capital measure

Disclosure of inside information pursuant to Article 17 MAR

NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR WITHIN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE DISTRIBUTION, PUBLICATION OR TRANSMISSION OF THIS COMMUNICATION IS UNLAWFUL. OTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION.

Leoben – To support the further development of the company, the Executive Board of AT&S considers to increase the share capital of the Company from authorized capital against cash contributions and to possibly implement further capital measures, whereby the aggregate volume of such potential capital measures may amount to up to 50% of the current share capital of AT&S. The details related thereto are still to be determined.

In order to support the success of such potential capital measures, AT&S has engaged in negotiations with Österreichische Beteiligungs AG (ÖBAG) concerning the potential subscription by the latter within the potential capital measures (whereby according to the current state of negotiations a participation of at least 25% +1 share of the share capital of AT&S would be sought). Moreover, the Executive Board of AT&S has decided to start talks with potential other new investors about a possible investment.

The implementation of potential capital measures and the potential investment by investors depends, among other things, on the passing of any required corporate resolutions, agreement with the potential investor as well as evaluation of the then prevailing market conditions.

The final approval of the Supervisory Board of AT&S is still outstanding. The Company will promptly inform once the necessary decision of the Supervisory Board has been passed and will, thereafter, provide timely information on the details of the potential capital measures.

Important Notice

This information neither constitutes any offer to sell nor any solicitation of any offer to buy or subscribe for any shares in the United States, Australia, Canada, Japan or any other jurisdiction in which such offer or solicitation may be unlawful, nor does it form part of any such offer or such solicitation. It is not intended to register any shares issued in a potential capital increase under the registration requirements of the U.S. Securities Act of 1933 (the "Securities Act").

Potential shares may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of potential shares in the United States of America.

This information may only be distributed and is only directed at (i) persons who are outside the United Kingdom, or (ii) professional investors within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), or (iii) high net worth companies and other persons to whom the information is lawfully made available falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "Relevant Persons"). Potential shares are available only to Relevant Persons and any invitation to subscribe for, purchase or otherwise acquire such securities or any offer or agreement in respect thereof will be made only to/with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents.

In any EEA Member State outside Austria, this communication is directed solely at "qualified investors" in that Member State within the meaning of Article 2(e) of the EU Regulation 2017/1129 (the "Prospectus Regulation").

This publication constitutes neither an offer to sell nor a solicitation to buy securities. A potential offer will be made solely by means of and on the basis of the published securities prospectus approved by the Financial Market Authority (FMA), the approval of which shall not be construed as an endorsement of the securities offered. An investment decision regarding any publicly offered securities of the Company should only be made on the basis of the securities prospectus. In the event that the potential capital increase is implemented, the related securities prospectus will be published without undue delay after approval by the FMA and made available in electronic form on the website of the Company; a printed copy will in such case be available upon request at the registered office of the Company, Fabriksgasse 13, 8700 Leoben, Austria, during normal business hours.

Stabilization / EU Regulation 2014/596 / EU Regulation 2016/1052 / Austrian Law.

This announcement does not constitute an offer of securities for sale or a solicitation of an offer to purchase securities in any jurisdiction.

AT & S Austria Technologie & Systemtechnik Aktiengesellschaft – Advanced Technologies & Solutions
AT&S is a globally leading manufacturer of high-end IC substrates and printed circuit boards. AT&S industrialises
leading-edge technologies for its core business segments IC Substrates, Mobile Devices, Automotive & Aerospace, Industrial and Medical. AT&S has a global presence with production sites in Austria (Leoben, Fehring) and plants in India (Nanjangud), China (Shanghai, Chongqing) and Korea (Ansan near Seoul). A new high-end production site for IC substrates is currently being established in Kulim, Malaysia. In Leoben, a European competence centre including series production is being built.
The company employs roughly 14,000 people. For further information please visit www.ats.net

Press contact:

Gerald Reischl, Vice President Corporate Communications

Tel: +43 3842 200 4252; Mobile: +43 664 8859 2452; [email protected]

Investor Relations contact:

Philipp Gebhardt, Senior Director Investor Relations

Tel: +43 3842 200 2274; Mobile: +43 664 7800 2274; [email protected]

AT & S Austria Technologie & Systemtechnik Aktiengesellschaft

Fabriksgasse 13
8700 Leoben / Austria
www.ats.net